Viewing Study NCT00901069


Ignite Creation Date: 2025-12-24 @ 10:50 PM
Ignite Modification Date: 2026-02-07 @ 3:13 PM
Study NCT ID: NCT00901069
Status: COMPLETED
Last Update Posted: 2016-10-17
First Post: 2009-05-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma
Sponsor: Shams Shakil
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Hodgkin Disease View
None Lymphoma, Non-Hodgkin View
Keywords: